Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019)

Aclaris Therapeutics has reported Change in Inventory over the past 2 years, most recently at -$3000.0 for Q4 2019.

  • Quarterly results put Change in Inventory at -$3000.0 for Q4 2019, up 99.74% from a year ago — trailing twelve months through Dec 2019 was -$605000.0 (changed N/A YoY), and the annual figure for FY2019 was -$605000.0, down 493.14%.
  • Change in Inventory for Q4 2019 was -$3000.0 at Aclaris Therapeutics, down from $4000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for ACRS hit a ceiling of $65000.0 in Q1 2019 and a floor of -$1.1 million in Q4 2018.